Discovery of novel benzofuran-based compounds with neuroprotective and immunomodulatory properties for Alzheimer's disease treatment
Authors:
- Serena MontanariSMSerena Montanari
- Ali Mokhtar MahmoudAMAli Mokhtar Mahmoud
- Alessandro RabbitoARAlessandro Rabbito
- Marina NaldiMNMarina Naldi
- Sabrina PetrallaSPSabrina Petralla
- Ignacio MoraledaIMIgnacio Moraleda
- Manuela BartoliniMBManuela Bartolini
- Isabel IriepaIsabel Iriepa
- Federica BellutiFederica Belluti
- Silvia GobbiSGSilvia Gobbi
- 1 September 2019
- journal article
- research article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 178, 243-258
Abstract
No abstract availableKeywords
Funding Information
- H2020 Marie Skłodowska-Curie Actions
This publication has 43 references indexed in Scilit:
- Cannabinoid Effects on β Amyloid Fibril and Aggregate Formation, Neuronal and Microglial-Activated Neurotoxicity In VitroCellular and Molecular Neurobiology, 2013
- 2-Arylbenzofuran-based molecules as multipotent Alzheimer's disease modifying agentsEuropean Journal of Medicinal Chemistry, 2012
- Biochemistry of Amyloid -Protein and Amyloid Deposits in Alzheimer DiseaseCold Spring Harbor Perspectives in Medicine, 2012
- The history of the cholinergic hypothesisBehavioural Brain Research, 2011
- Soluble amyloid β-protein dimers isolated from Alzheimer cortex directly induce Tau hyperphosphorylation and neuritic degenerationProceedings of the National Academy of Sciences, 2011
- CB2: a cannabinoid receptor with an identity crisisBritish Journal of Pharmacology, 2010
- Endocannabinoid signaling in microglial cellsNeuropharmacology, 2009
- Biology and therapeutic potential of cannabinoid CB2receptor inverse agonistsBritish Journal of Pharmacology, 2008
- Attenuated amyloid-β aggregation and neurotoxicity owing to methionine oxidationNeuroReport, 2007
- CHARMM: A program for macromolecular energy, minimization, and dynamics calculationsJournal of Computational Chemistry, 1983